Marek Waluga

Author PubWeight™ 4.73^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Serum chemerin and vaspin in non-alcoholic fatty liver disease.	Scand J Gastroenterol	2010	1.69
2	sPECAM-1 and sVCAM-1: Role in Pathogenesis and Diagnosis of Chronic Hepatitis C and Association with Response to Antiviral Therapy.	Therap Adv Gastroenterol	2009	0.77
3	Omentin serum concentration and hepatic expression in chronic hepatitis C patients - together or apart?	Pol J Pathol	2015	0.77
4	Serum vaspin may be a good indicator of fibrosis in chronic hepatitis C and is not altered by antiviral therapy.	Pol J Pathol	2012	0.77
5	Motility disorders, functional gastrointestinal disorders, inflammatory bowel disease and cardiac rhythm disturbances - is there a link? Review of literature.	Curr Drug Targets	2015	0.76
6	Hepatic chemerin mRNA in morbidly obese patients with nonalcoholic fatty liver disease.	Pol J Pathol	2017	0.75
7	Vaspin mRNA levels in the liver of morbidly obese women with nonalcoholic fatty liver disease.	Pol J Pathol	2017	0.75
8	An unusual cause of hepatic encephalopathy.	Pol Arch Med Wewn	2015	0.75